This data gave evidence that HGF/VEGF plasmid injection to ischemic muscle stimulates development of impaired glucose tolerance, but not insulin resistance without significant long-term metabolic consequences (FBG, body weight). This evidence concerns the gene INS and Impaired glucose tolerance.